Saskatchewan announced to fund clinical trials of a new procedure that could offer hope to people with multiple sclerosis, but it appears Alberta MS patients will have to wait.

Saskatchewan Premier Brad Wall told media that he wanted Saskatchewan to be the first to help pay for clinical trials into the controversial treatment and hopes other provinces would join Saskatchewan in funding studies.

Alberta Health and Wellness will only acknowledge that it is an emotional subject. Andy Weiler with Alberta Health and Wellness said that People look at this liberation treatment with a lot of hope and optimism.

It was a year-and-a-half ago when 29-year-old Thomas Deering was diagnosed with MS. His career as an electrician appears to be over as his hands are now numb. He says he has received a lot of support from family members but has temporarily lost his eye sight and often feels fatigued.

Though it is frustrating for Deering, he continues to remain hopeful at this time and believes that there will be cure before his death. Deering says he is excited about Saskatchewan's announcement except it'll be some time before treatment occurs.

Italian researcher Dr. Paolo Zamboni claims many MS patients have narrow veins. He developed a procedure similar to angioplasty to improve blood flow to the brain.

The MS Society of Canada feels other provinces should step up just as Saskatchewan has.

Darrel Gregory with the MS Society of Canada hopes that it won't only be Saskatchewan but somewhere down the road it'll be Alberta and indeed all provinces collaborating to offer clinical trials all across the country.

Critics also feel the province could help Albertans suffering from MS by funding clinical trials of the experimental treatment.

NDP leader Brian Mason says he has written to Health Minister Gene Zwozdesky urging him to follow the lead of Saskatchewan and support the clinical trials.

And with no doctors widely offering the procedure in country, many Canadian MS patients have been opted to travel overseas to find clinics willing to provide the treatment, but with the cost running in the thousands of dollars.